Reflection Biotechnologies
Manufacturing · China · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Sha Tin, Sha Tin, ChinaPhone Number
+852 36898551Website
www.reflectionbio.comRevenue
$5.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Reflection Biotechnologies
Reflection Biotechnologies, also known as ReflectionBio, is a patient-driven gene therapy company focused on rare and challenging ocular diseases, particularly Bietti's Crystalline Dystrophy (BCD). Founded by a rare disease patient and family, the company emphasizes the involvement of patients in research and development to address their needs. ReflectionBio is developing a proprietary gene therapy candidate, RBIO-101, aimed at treating BCD, a condition affecting approximately 67,000 patients globally. The company aims to bring hope to patients suffering from genetic causes of blindness.Explore more
Reflection Biotechnologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Reflection Biotechnologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Reflection Biotechnologies, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Reflection Biotechnologies launches new products
Click to see if Reflection Biotechnologies had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Reflection Biotechnologies has new funding data
Congratulate Masked Content for being promoted to Masked Content at Reflection Biotechnologies
Earning: See what the market has to say on Reflection Biotechnologies recently announced quarterly report
Check out if Reflection Biotechnologies is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Reflection Biotechnologies has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Reflection Biotechnologies
Find more new buyers
Compare Similar Companies to Reflection Biotechnologies
Compare insights from companies similar to Reflection Biotechnologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Reflection Biotechnologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Reflection Biotechnologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Reflection Biotechnologies.
Reflection Biotechnologies Tech Stack
A closer look at the technologies used by Reflection Biotechnologies
See more technologies
Reflection Biotechnologies News & Media
Patient-Driven Gene Therapy Company ReflectionBio Receives Orphan Drug Designation From U.S. FDA For the Treatment of Bietti's Crystalline Dystrophy (BCD)
HONG KONG & NEW YORK--(BUSINESS WIRE)--Reflection Biotechnologies Limited ("ReflectionBio"), a gene therapy company committed to the research and development of life-changing treatments for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ReflectionBio's RBIO-101 program (AAV.CYP4V2), an AAV-based gene therapy product for treating Bietti's Crystalline Dystrophy (BCD). "Receiving orphan drug designation from the FDA is a miles
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Reflection Biotechnologies
Sign Up For FreeTo access detailed company insights
Reflection Biotechnologies, also known as ReflectionBio, is a patient-driven gene therapy company focused on rare and challenging ocular diseases, particularly Bietti's Crystalline Dystrophy (BCD). Founded by a rare disease patient and family, the company emphasizes the involvement of patients in research and development to address their needs. Ref... Read More
